| Drug Name |
Kanamycin |
| Drug ID |
BADD_D01226 |
| Description |
Kanamycin (also known as kanamycin A) is an aminoglycoside bacteriocidal antibiotic, available in oral, intravenous, and intramuscular forms, and used to treat a wide variety of infections. Kanamycin is isolated from the bacterium Streptomyces kanamyceticus and its most commonly used form is kanamycin sulfate. |
| Indications and Usage |
For treatment of infections where one or more of the following are the known or suspected pathogens: E. coli, Proteus species (both indole-positive and indole-negative), E. aerogenes, K. pneumoniae, S. marcescens, and Acinetobacter species. |
| Marketing Status |
approved; investigational; vet_approved |
| ATC Code |
A07AA08; J01GB04; S01AA24 |
| DrugBank ID |
DB01172
|
| KEGG ID |
D03262; D00866
|
| MeSH ID |
D007612
|
| PubChem ID |
6032
|
| TTD Drug ID |
D0YV1Q
|
| NDC Product Code |
Not Available |
| UNII |
RUC37XUP2P
|
| Synonyms |
Kanamycin | Kantrex | Kanamycin A | Kanamycin Sulfate |
